ASSESSMENT OF PHYSICIANS' RESPONSE TO TEXT ALERTS IN PATIENTS WITH REDUCED RENAL FUNCTION BY USING A TEXT MESSAGE ALERTING SYSTEM
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2014, Vol 6, Issue 8
Abstract
Introduction: Adverse drug events are mostly dose dependent and preventable. About 50% of these adverse effects are due to inappropriate dosing especially in patients with renal failure.Objective: We aimed to determine the impact of short message alerting on physicians' drug dosing of patients with decreased renal function.Methods: Eighteen physicians accepted to enroll in the study. Their patients who received at least one of the six selected drugs were selected for evaluation. The patients with an estimated glomerular filtration rate of 50 ml/minute or lower were randomly divided into two groups of case and control. An alert was sent to the physician in charge of the intervention (case) group. Physicians' reactions was recorded as "dose adjustment", "discontinuation of medication" or "none" and were compared in both groups. The reaction time of physicians before and after receiving alerts was recorded as well.Results: One hundred and thirty seven patients entered the study. The study results showed a significant difference in overall changes between the two groups (*** P <0.001). The rate of dose adjustment increased significantly after sending alerts to physicians (*** P <0.001). However, there was not a significant difference regarding discontinuation of medication between groups (P= 0.76). On the other hand, prompt reaction of physicians (0-6 hours after sending short message) significantly increased after intervention (* P < 0.05). Nevertheless, physicians' reaction time in 6-24 hours and 24-48 hours was not changed significantly after intervention.Conclusion: The results of this study show that informing physicians about the renal function of the patients leads to appropriate dosing.Â
Authors and Affiliations
Aida Sefidani Forough, Fanak Fahimi, Nima Naderi
Keywords
Related Articles
- EP ID EP579770
- DOI -
- Views 72
- Downloads 0
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF AZILSARTAN MEDOXIMIL AND CHLORTHALIDONE IN BULK FORM AND FORMULATION USING QUALITY BY DESIGN
Objective: Development of an accurate, precise, robust, sensitive, economical and rapid isocratic reversed-phase high-performance liquid chromatography (RP-HPLC) method complying quality by design (QbD) trends for simult...
ACUTE AND SUB-CHRONIC TOXICOLOGICAL STUDIES ON METHANOLIC STEM EXTRACT OF ACALYPHA INDICA LINN IN ALBINO WISTAR RATS
Objective: The present study was aimed to investigate safety evaluation studies of methanolic stem extract of A. indica (AIS-ME) through acute and sub-chronic toxicity studies in albino wistar rats.Methods: Acute toxicit...
POPULATION PHARMACOKINETICS OF CONTINUOUS INFUSION OF FACTOR VIII IN HEMOPHILIA-A PATIENTS UNDERGOING ORTHOPEDIC SURGERY
Objective: to develop a population pharmacokinetic model taking into account blood losses during and after orthopedic surgery in adult hemophilia A patients receiving infusion of coagulation factor VIII, and to evaluate...
ETHNOMEDICINAL, PHYTOCHEMICAL AND PHARMACOLOGICAL ASPECTS OF FLACOURTIA JANGOMAS: A REVIEW
Flacourtia jangomas (Lour.) Raeusch., a small tree of Willow family distributed throughout tropical regions of East Africa and Asia is well-known for its culinary and medicinal uses. The plant has received increasing int...
ISOLATION OF CUCURBITACIN-B FROM CUCUMIS CALLOSUS AND ITS HYPOGLYCEMIC EFFECT IN ISOLATED RAT ENTEROCYTES
Objective: The pericarp of fruits of Cucumis callous (Rottl.) Cogn. (Cucurbitaceae) is traditionally used for curing diabetes, epilepsy, and diarrhea. It has an active compound include Cucurbitacin-B (CuB), which acts as...